Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is AT&T Stock a Buy Now?


AT (NYSE: T) posted its second-quarter report on July 26. Its revenue rose 1% year over year to $29.9 billion, which missed analysts' estimates by $30 million. Its adjusted earnings per share (EPS) fell 3% to $0.63 but beat the consensus forecast by three cents.

AT's stock barely budged after that mixed report, and it remains down nearly 20% this year. It certainly looks cheap AT six times forward earnings and pays a hefty forward dividend yield of 7.5% -- but is it a worthwhile long-term investment?

Image source: AT

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

€0.057
14.140%
A very strong showing by Allergy Therapeutics PLC today, with an increase of €0.007 (14.140%) compared to yesterday's price.

Like: 0
T
Share

Comments